Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2012 (2012), Article ID 748984, 10 pages
http://dx.doi.org/10.1155/2012/748984
Clinical Study

Variation in APOL1 Contributes to Ancestry-Level Differences in HDLc-Kidney Function Association

1Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-5635, USA
2Suizhou Central Hospital, Suizhou, Hubei 441300, China
3Department of Medicine, University of Lagos, Lagos 101017, Nigeria
4Department of Medicine, University of Nigeria Teaching Hospital, Enugu 400001, Nigeria
5Department of Medicine, University of Science and Technology, Kumasi, Ghana
6Department of Medicine, University of Ibadan, Ibadan 200284, Nigeria
7Department of Medicine and Therapeutics, University of Ghana Medical School, Accra, Ghana

Received 7 February 2012; Revised 26 June 2012; Accepted 11 July 2012

Academic Editor: Rudolph A. Rodriguez

Copyright © 2012 Amy Rebecca Bentley et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. O. Attman and O. Samuelsson, “Dyslipidemia of kidney disease,” Current Opinion in Lipidology, vol. 20, no. 4, pp. 293–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Trevisan, A. R. Dodesini, and G. Lepore, “Lipids and renal disease,” Journal of the American Society of Nephrology, vol. 17, supplement 2, pp. S145–S147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Schlondorff, “Cellular mechanisms of lipid injury in the glomerulus,” American Journal of Kidney Diseases, vol. 22, no. 1, pp. 72–82, 1993. View at Google Scholar · View at Scopus
  4. C. K. Abrass, “Cellular lipid metabolism and the role of lipids in progressive renal disease,” American Journal of Nephrology, vol. 24, no. 1, pp. 46–53, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. L. S. Dalrymple and G. A. Kaysen, “The effect of lipoproteins on the development and progression of renal disease,” American Journal of Nephrology, vol. 28, no. 5, pp. 723–731, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. R. N. Foley, C. Wang, J. J. Snyder, A. D. Rule, and A. J. Collins, “Kidney function and risk triage in adults: threshold values and hierarchical importance,” Kidney International, vol. 79, no. 1, pp. 99–111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. R. M. A. Henry, P. J. Kostense, G. Bos et al., “Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn study,” Kidney International, vol. 62, no. 4, pp. 1402–1407, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Matsushita, E. Selvin, L. D. Bash, N. Franceschini, B. C. Astor, and J. Coresh, “Change in estimated GFR associates with coronary heart disease and mortality,” Journal of the American Society of Nephrology, vol. 20, no. 12, pp. 2617–2624, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. E. Rifkin, M. G. Shlipak, R. Katz et al., “Rapid kidney function decline and mortality risk in older adults,” Archives of Internal Medicine, vol. 168, no. 20, pp. 2212–2218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. I. H. de Boer, B. C. Astor, H. Kramer et al., “Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 1, pp. 125–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Hoebel, J. H. de Ridder, and L. Malan, “The association between anthropometric parameters, the metabolic syndrome and microalbuminuria in black Africans: the SABPA study,” Cardiovascular Journal of Africa, vol. 21, no. 3, pp. 148–152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Muntner, J. Coresh, J. C. Smith, J. Eckfeldt, and M. J. Klag, “Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study,” Kidney International, vol. 58, no. 1, pp. 293–301, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. J. C. Verhave, H. L. Hillege, J. G. M. Burgerhof, R. T. Gansevoort, D. De Zeeuw, and P. E. De Jong, “The association between atherosclerotic risk factors and renal function in the general population,” Kidney International, vol. 67, no. 5, pp. 1967–1973, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Yamagata, K. Ishida, T. Sairenchi et al., “Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study,” Kidney International, vol. 71, no. 2, pp. 159–166, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. S. Schaeffner, T. Kurth, G. C. Curhan et al., “Cholesterol and the risk of renal dysfunction in apparently healthy men,” Journal of the American Society of Nephrology, vol. 14, no. 8, pp. 2084–2091, 2003. View at Google Scholar · View at Scopus
  16. M. Manttari, E. Tiula, T. Alikoski, and V. Manninen, “Effects of hypertension and dyslipidemia on the decline in renal function,” Hypertension, vol. 26, no. 4, pp. 670–675, 1995. View at Google Scholar · View at Scopus
  17. J. A. Krikken, R. T. Gansevoort, and R. P. F. Dullaart, “Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease,” Journal of Lipid Research, vol. 51, no. 7, pp. 1982–1990, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. E. Tarver-Carr, N. R. Powe, M. S. Eberhardt et al., “Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors,” Journal of the American Society of Nephrology, vol. 13, no. 9, pp. 2363–2370, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. N. R. Burrows, Y. Li, and D. E. Williams, “Racial and ethnic differences in trends of end-stage renal disease: United States, 1995 to 2005,” Advances in Chronic Kidney Disease, vol. 15, no. 2, pp. 147–152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Y. Hsu, F. Lin, E. Vittinghoff, and M. G. Shlipak, “Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States,” Journal of the American Society of Nephrology, vol. 14, no. 11, pp. 2902–2907, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. E. Schutte, R. Schutte, H. W. Huisman et al., “Classifying Africans with the metabolic syndrome,” Hormone and Metabolic Research, vol. 41, no. 2, pp. 79–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. A. E. Sumner, J. Zhou, A. Doumatey et al., “Low HDL-cholesterol with normal triglyceride levels is the most common lipid pattern in West Africans and African Americans with metabolic syndrome: implications for cardiovascular disease prevention,” CVD Prevention and Control, vol. 5, no. 3, pp. 75–80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. B. I. Freedman, J. B. Kopp, C. D. Langefeld et al., “The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans,” Journal of the American Society of Nephrology, vol. 21, no. 9, pp. 1422–1426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. Reeves-Daniel, J. A. Depalma, A. J. Bleyer et al., “The APOL1 gene and allograft survival after kidney transplantation,” American Journal of Transplantation, vol. 11, no. 5, pp. 1025–1030, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. C. N. Rotimi, G. M. Dunston, K. Berg et al., “In search of susceptibility genes for type 2 diabetes in West Africa: the design and results of the first phase of the AADM study,” Annals of Epidemiology, vol. 11, no. 1, pp. 51–58, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Adeyemo, N. Gerry, G. Chen et al., “A genome-wide association study of hypertension and blood pressure in African Americans,” PLoS Genetics, vol. 5, no. 7, Article ID e1000564, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. Center for Disease Control and Prevention, National Health and Nutrition Examination Protocol, Center for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, Md, USA, 2003-2004.
  28. Center for Disease Control and Prevention, National Health and Nutrition Examination Protocol, Center for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, Md, USA, 2007-2008.
  29. J. D. Cohen, M. J. Cziraky, Q. Cai et al., “30-year trends in serum lipids among united states adults: results from the national health and nutrition examination surveys II, III, and 1999–2006,” American Journal of Cardiology, vol. 106, no. 7, pp. 969–975, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  31. K. L. Mohlke, M. R. Erdos, L. J. Scott et al., “High-throughput screening for evidence of association by using mass spectrometry genotyping on DNA pools,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 26, pp. 16928–16933, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. A. S. Levey, L. A. Stevens, C. H. Schmid et al., “A new equation to estimate glomerular filtration rate,” Annals of Internal Medicine, vol. 150, no. 9, pp. 604–612, 2009. View at Google Scholar · View at Scopus
  33. G. Genovese, D. J. Friedman, M. D. Ross et al., “Association of trypanolytic ApoL1 variants with kidney disease in African Americans,” Science, vol. 329, no. 5993, pp. 841–845, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. A. L. Price, N. J. Patterson, R. M. Plenge, M. E. Weinblatt, N. A. Shadick, and D. Reich, “Principal components analysis corrects for stratification in genome-wide association studies,” Nature Genetics, vol. 38, no. 8, pp. 904–909, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Shriner, “Investigating population stratification and admixture using eigenanalysis of dense genotypes,” Heredity, vol. 107, pp. 413–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Lin, S. Judd, A. Le et al., “Associations of dietary fat with albuminuria and kidney dysfunction,” American Journal of Clinical Nutrition, vol. 92, no. 4, pp. 897–904, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. E. S. Ford, C. Li, and G. Zhao, “Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US,” Journal of Diabetes, vol. 2, no. 3, pp. 180–193, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. G. M. M. Hosain, M. Rahman, K. J. Williams, and A. B. Berenson, “Racial differences in the association between body fat distribution and lipid profiles among reproductive-age women,” Diabetes and Metabolism, vol. 36, no. 4, pp. 278–285, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. H. A. Taylor Jr., S. A. Coady, D. Levy et al., “Relationships of BMI to cardiovascular risk factors differ by ethnicity,” Obesity, vol. 18, no. 8, pp. 1638–1645, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S. R. Mulukutla, L. Venkitachalam, O. C. Marroquin et al., “Population variations in atherogenic dyslipidemia: a report from the HeartSCORE and IndiaSCORE Studies,” Journal of Clinical Lipidology, vol. 2, no. 6, pp. 410–417, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Paramsothy, R. Knopp, A. G. Bertoni, M. Y. Tsai, T. Rue, and S. R. Heckbert, “Combined hyperlipidemia in relation to race/ethnicity, obesity, and insulin resistance in the multi-ethnic study of atherosclerosis,” Metabolism, vol. 58, no. 2, pp. 212–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. A. J. Proudler, I. F. Godsland, R. Bruce, M. Seed, and V. Wynn, “Lipid and carbohydrate metabolic risk markers for coronary heart disease and blood pressure in healthy non-obese premenopausal women of different racial origins in the United Kingdom,” Metabolism, vol. 45, no. 3, pp. 328–333, 1996. View at Publisher · View at Google Scholar · View at Scopus
  43. L. A. Stevens, M. A. Claybon, C. H. Schmid et al., “Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities,” Kidney International, vol. 79, no. 5, pp. 555–562, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999. View at Google Scholar · View at Scopus
  45. E. D'Adamo, V. Northrup, R. Weiss et al., “Ethnic differences in lipoprotein subclasses in obese adolescents: importance of liver and intraabdominal fat accretion,” American Journal of Clinical Nutrition, vol. 92, no. 3, pp. 500–508, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. J. L. Johnson, C. A. Slentz, B. D. Duscha et al., “Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study,” Atherosclerosis, vol. 176, no. 2, pp. 371–377, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. I. Miljkovic-Gacic, C. H. Bunker, R. E. Ferrell et al., “Lipoprotein subclass and particle size differences in Afro-Caribbeans, African Americans, and white Americans: associations with hepatic lipase gene variation,” Metabolism, vol. 55, no. 1, pp. 96–102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. B. F. Voight, G. M. Peloso, M. Orho-Melander et al., “Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study,” The Lancet, vol. 380, no. 9841, pp. 572–580, 2012. View at Google Scholar
  49. D. Lloyd-Jones, R. J. Adams, T. M. Brown et al., “Executive summary: heart disease and stroke statistics-2010 update: a report from the american heart association,” Circulation, vol. 121, no. 7, pp. e46–e215, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. I. Dagogo-Jack and S. Dagogo-Jack, “Dissociation between cardiovascular risk markers and clinical outcomes in African Americans: need for greater mechanistic insight,” Current Cardiovascular Risk Reports, vol. 5, pp. 200–206, 2011. View at Google Scholar
  51. T. Gaillard, “Insulin resistance and cardiovascular disease risk in black people of the African Diaspora,” Current Cardiovascular Risk Reports, vol. 4, pp. 186–194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Osei, “Metabolic syndrome in blacks: are the criteria right?” Current Diabetes Reports, vol. 10, no. 3, pp. 199–208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. A. E. Sumner, “Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults,” Journal of Pediatrics, vol. 155, no. 3, pp. S7.e7–S7.e11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. B. I. Freedman, C. D. Langefeld, M. Murea et al., “Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans,” Nephrology Dialysis Transplantation, vol. 26, no. 11, pp. 3805–3810, 2011. View at Google Scholar
  55. R. H. Knopp, P. Paramsothy, B. M. Retzlaff et al., “Gender differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease,” Current Atherosclerosis Reports, vol. 7, no. 6, pp. 472–479, 2005. View at Publisher · View at Google Scholar · View at Scopus